TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth.
about
Impact of Early-Life Exposures to Infections, Antibiotics, and Vaccines on Perinatal and Long-term Health and Disease.3M-052 as an adjuvant for a PLGA microparticle-based Leishmania donovani recombinant protein vaccine.Adjuvanting an inactivated influenza vaccine with conjugated R848 improves the level of antibody present at 6months in a nonhuman primate neonate model.An R848 adjuvanted influenza vaccine promotes early activation of B cells in the draining lymph node of nonhuman primate neonates.Identification and Characterization of Stimulator of Interferon Genes As a Robust Adjuvant Target for Early Life Immunization.Oxidative stress diseases unique to the perinatal period: A window into the developing innate immune response.Adjuvant Effect of Bacille Calmette-Guérin on Hepatitis B Vaccine Immunogenicity in the Preterm and Term Newborn.Neonatal Immunization: Rationale, Current State, and Future Prospects.Overcoming the Neonatal Limitations of Inducing Germinal Centers through Liposome-Based Adjuvants Including C-Type Lectin Agonists Trehalose Dibehenate or Curdlan.Pentoxifylline, dexamethasone and azithromycin demonstrate distinct age-dependent and synergistic inhibition of TLR- and inflammasome-mediated cytokine production in human newborn and adult blood in vitro.Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for Entamoeba histolytica.Adjuvant-dependent enhancement of HIV Env-specific antibody responses in infant rhesus macaquesThe Impact of IgG transplacental transfer on early life immunity
P2860
Q38660625-9A27791A-7FAE-4F3A-8554-9B4BB58A1632Q39575305-99B7DFEF-7718-44C5-BDAB-2751AB062BC8Q41926881-82CA182B-D4DD-4839-82C7-1BF9B2C9B4E5Q41931711-725399C8-A907-4643-B509-9AFF7F5D33EFQ47169865-E95FABA7-3D06-4DF1-997C-5576692805F1Q47940232-6404968D-8516-42EA-95CB-12FFFCC9002AQ49588673-25FB1F3F-0338-41EA-A42A-087C817D89F0Q52579157-6797C98F-E59B-4239-B79A-71825EF0E4B1Q52655234-406F4969-388E-439A-8CEB-564A65593B1AQ54223958-B17676A3-2102-4D1B-BF60-D40FAD5397FCQ55349305-A8A346A5-54DF-41CD-8430-FD13E9BF5F34Q56345991-C50B0853-000A-4BCF-8BDE-389BBCD4FE1AQ56505186-72CD5BF8-3A0D-4F43-950A-28E7423D3658
P2860
TLR7/8 adjuvant overcomes newborn hyporesponsiveness to pneumococcal conjugate vaccine at birth.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 March 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
TLR7/8 adjuvant overcomes newb ...... al conjugate vaccine at birth.
@en
TLR7/8 adjuvant overcomes newb ...... al conjugate vaccine at birth.
@nl
type
label
TLR7/8 adjuvant overcomes newb ...... al conjugate vaccine at birth.
@en
TLR7/8 adjuvant overcomes newb ...... al conjugate vaccine at birth.
@nl
prefLabel
TLR7/8 adjuvant overcomes newb ...... al conjugate vaccine at birth.
@en
TLR7/8 adjuvant overcomes newb ...... al conjugate vaccine at birth.
@nl
P2093
P2860
P1433
P1476
TLR7/8 adjuvant overcomes newb ...... cal conjugate vaccine at birth
@en
P2093
Al Ozonoff
Andrew A Lackner
Annette Scheid
Cecily C Midkiff
Christy J Mancuso
David J Dowling
Dhohyung Kim
Dmitri Smirnov
Ilana Bergelson
James L Blanchard
P2860
P304
P356
10.1172/JCI.INSIGHT.91020
P577
2017-03-23T00:00:00Z